Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

AIM: The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of available clinical trials. METHODS: PubMed was reviewed for phase III randomized trials with axitinib, pazopanib...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Iacovelli, Roberto, Palazzo, Antonella, Procopio, Giuseppe, Santoni, Matteo, Trenta, Patrizia, De Benedetto, Angelina, Mezi, Silvia, Cortesi, Enrico
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 2014
Pynciau:
Reviews
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4093918/
https://ncbi.nlm.nih.gov/pubmed/23981115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12231
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg